Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Non-coding RNAs help control hair growth in cashmere goats.

A man with four autoimmune diseases suggests a new category for multiple autoimmune syndrome.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Mesotherapy is a minimally invasive treatment with potential benefits and risks, requiring standardized practices and further investigation.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

The review suggests new ways to classify ejaculation problems and recommends different treatments based on the type of issue.

The assay effectively detects hormonal activity of certain chemicals.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Metformin lowers prolactin in men with normal hair but not in those with early hair loss.

Interleukin-1 increases keratin K6 production in skin cells.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

Accurate diagnosis of hyperandrogenism, especially PCOS, is crucial for managing fertility and metabolic risks in women.

Lower baseline prolactin levels may lead to better insulin resistance improvement with metformin in PCOS patients.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Early diagnosis, genetic testing, and innovative treatments are crucial for managing complex medical conditions.